Excellent Result With the Use of Single-Dose OK-432 in Cervical Macrocystic Lymphangioma

    loading  Checking for direct PDF access through Ovid

Abstract

Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.

Related Topics

    loading  Loading Related Articles